Generic Sterile Injectables Market Poised to Grow at a Robust Pace Due to Increasing Prevalence of Chronic Diseases
Generic sterile injectables are medicinal products administered intravenously or through injection into body cavities. They are widely used for treating complex chronic illnesses like cancer, diabetes and autoimmune disorders. The global generic sterile injectables market is estimated to be valued at US$ 38,706.5 Mn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2023...
0 Comments
0 Shares